About Us News & Events Investors Careers
Search
Products Solutions Technologies Disease States Contact Us
Tox STATus

Providing the solutions for molecular diagnostics.

At Nanogen, Inc., we develop diagnostic products that enable physicians to deliver improved patient care. Our products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care.

Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. Our business focus is to bring better results to diagnostics and healthcare.

Latest news More
Nanogen Reports 2008 First Quarter Financial Results
Nanogen and Thermo Fisher Scientific Partner to Provide Molecular Biology Products to Research Market
DRI Capital Inc. Acquires Royalties from Nanogen Inc. for US $10 Million

Upcoming Events More
May 17 - 20, 2008   National Commision on Correctional Health Care (NCCHC)
May 29 - Jun 4, 2008   American Transplant Congress (ATC)
Jun 1 - 5, 2008   American Society for Microbiology (ASM)